These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 9755825

  • 1. Apoptosis and liver fibrosis: antifibrotic strategies.
    Calès P.
    Biomed Pharmacother; 1998; 52(6):259-63. PubMed ID: 9755825
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis.
    Elsharkawy AM, Oakley F, Mann DA.
    Apoptosis; 2005 Oct; 10(5):927-39. PubMed ID: 16151628
    [Abstract] [Full Text] [Related]

  • 5. Liver fibrosis: from the bench to clinical targets.
    Pinzani M, Rombouts K.
    Dig Liver Dis; 2004 Apr; 36(4):231-42. PubMed ID: 15115333
    [Abstract] [Full Text] [Related]

  • 6. Cirrhosis--can we reverse hepatic fibrosis?
    Tangkijvanich P, Yee HF.
    Eur J Surg Suppl; 2002 Apr; (587):100-12. PubMed ID: 16144208
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hepatic fibrosis--role of hepatic stellate cell activation.
    Safadi R, Friedman SL.
    MedGenMed; 2002 Jul 15; 4(3):27. PubMed ID: 12466770
    [Abstract] [Full Text] [Related]

  • 10. Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved.
    Guyot C, Lepreux S, Combe C, Doudnikoff E, Bioulac-Sage P, Balabaud C, Desmoulière A.
    Int J Biochem Cell Biol; 2006 Feb 15; 38(2):135-51. PubMed ID: 16257564
    [Abstract] [Full Text] [Related]

  • 11. Hepatic stellate cells as a target for the treatment of liver fibrosis.
    Bataller R, Brenner DA.
    Semin Liver Dis; 2001 Aug 15; 21(3):437-51. PubMed ID: 11586471
    [Abstract] [Full Text] [Related]

  • 12. [Novel factors playing a role in the pathomechanism of diffuse liver diseases: apoptosis and hepatic stem cells].
    Schaff Z, Nagy P.
    Orv Hetil; 2004 Aug 29; 145(35):1787-93. PubMed ID: 15493221
    [Abstract] [Full Text] [Related]

  • 13. Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study.
    Carpino G, Franchitto A, Morini S, Corradini SG, Merli M, Gaudio E.
    Ital J Anat Embryol; 2004 Aug 29; 109(4):225-38. PubMed ID: 15717457
    [Abstract] [Full Text] [Related]

  • 14. Liver fibrosis: searching for cell model answers.
    Gutiérrez-Ruiz MC, Gómez-Quiroz LE.
    Liver Int; 2007 May 29; 27(4):434-9. PubMed ID: 17403182
    [Abstract] [Full Text] [Related]

  • 15. Stephania tetrandra prevents and regresses liver fibrosis induced by carbon tetrachloride in rats.
    Chor JS, Yu J, Chan KK, Go YY, Sung JJ.
    J Gastroenterol Hepatol; 2009 May 29; 24(5):853-9. PubMed ID: 19220659
    [Abstract] [Full Text] [Related]

  • 16. Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis.
    Taimr P, Higuchi H, Kocova E, Rippe RA, Friedman S, Gores GJ.
    Hepatology; 2003 Jan 29; 37(1):87-95. PubMed ID: 12500193
    [Abstract] [Full Text] [Related]

  • 17. Inverse association between hepatic stellate cell apoptosis and fibrosis in chronic hepatitis C virus infection.
    Gonzalez SA, Fiel MI, Sauk J, Canchis PW, Liu RC, Chiriboga L, Yee HT, Jacobson IM, Talal AH.
    J Viral Hepat; 2009 Feb 29; 16(2):141-8. PubMed ID: 19175868
    [Abstract] [Full Text] [Related]

  • 18. Liver extracellular matrix in health and disease.
    Bedossa P, Paradis V.
    J Pathol; 2003 Jul 29; 200(4):504-15. PubMed ID: 12845618
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.
    Friedman SL.
    Nat Clin Pract Gastroenterol Hepatol; 2004 Dec 29; 1(2):98-105. PubMed ID: 16265071
    [Abstract] [Full Text] [Related]

  • 20. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners.
    Radaeva S, Sun R, Jaruga B, Nguyen VT, Tian Z, Gao B.
    Gastroenterology; 2006 Feb 29; 130(2):435-52. PubMed ID: 16472598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.